242 related articles for article (PubMed ID: 36777339)
1. Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: A systematic review and meta-analysis.
Zhang H; Li X; Zhang N; Tian L
Front Endocrinol (Lausanne); 2023; 14():1083171. PubMed ID: 36777339
[TBL] [Abstract][Full Text] [Related]
2. Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism.
Ozmen B; Ozmen D; Parildar Z; Mutaf I; Bayindir O
Endocr Res; 2007; 32(1-2):1-8. PubMed ID: 18271501
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
[TBL] [Abstract][Full Text] [Related]
4. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
Christ-Crain M; Morgenthaler NG; Meier C; Müller C; Nussbaumer C; Bergmann A; Staub JJ; Müller B
Swiss Med Wkly; 2005 Sep; 135(37-38):549-54. PubMed ID: 16333765
[TBL] [Abstract][Full Text] [Related]
5. The effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide concentrations.
Manuchehri AM; Jayagopal V; Kilpatrick ES; Atkin SL
Ann Clin Biochem; 2006 May; 43(Pt 3):184-8. PubMed ID: 16704752
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
[TBL] [Abstract][Full Text] [Related]
7. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
10. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
[TBL] [Abstract][Full Text] [Related]
11. Stress-delta B-type Natriuretic Peptide Levels as a Test for Inducible Myocardial Ischemia: A Systematic Review and Meta-Analysis.
Kheang S; Rodrigues CG; Vissoci JRN; Hassan A; Muller C; Muller D; Limkakeng AT
Cureus; 2020 Mar; 12(3):e7165. PubMed ID: 32257708
[TBL] [Abstract][Full Text] [Related]
12. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism.
Pakuła D; Marek B; Kajdaniuk D; Krysiak R; Kos-Kudła B; Pakuła P; Gatnar A; Borgiel-Marek H; Nowak M; Siemińska L; Głogowska-Szeląg J; Ostrowska Z
Endokrynol Pol; 2011; 62(6):523-8. PubMed ID: 22144219
[TBL] [Abstract][Full Text] [Related]
15. Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis.
Cao YT; Zhang KY; Sun J; Lou Y; Lv TS; Yang X; Zhang WH; Yu JY; Wu QB; Zhou XQ
Front Immunol; 2022; 13():1089469. PubMed ID: 36618418
[TBL] [Abstract][Full Text] [Related]
16. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
18. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
[TBL] [Abstract][Full Text] [Related]
20. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
